Please use this identifier to cite or link to this item: http://repositorio.unicamp.br/jspui/handle/REPOSIP/327713
Type: Artigo
Title: Increased Toll-like Receptors And P53 Levels Regulate Apoptosis And Angiogenesis In Non-muscle Invasive Bladder Cancer: Mechanism Of Action Of P-mapa Biological Response Modifier
Author: Garcia
Patrick Vianna; Ferreira Seiva
Fabio Rodrigues; Carniato
Amanda Pocol; de Mello Junior
Wilson; Duran
Nelson; Macedo
Alda Maria; de Oliveira
Alexandre Gabarra; Romih
Rok; Nunes
Iseu da Silva; Nunes
Odilon da Silva; Favaro
Wagner Jose
Abstract: The new modalities for treating patients with non-muscle invasive bladder cancer (NMIBC) for whom BCG (Bacillus Calmette-Guerin) has failed or is contraindicated are recently increasing due to the development of new drugs. Although agents like mitomycin C and BCG are routinely used, there is a need for more potent and/or less-toxic agents. In this scenario, a new perspective is represented by P-MAPA (Protein Aggregate Magnesium-Ammonium Phospholinoleate-Palmitoleate Anhydride), developed by Farmabrasilis (non-profit research network). This study detailed and characterized the mechanisms of action of P-MAPA based on activation of mediators of Toll-like Receptors (TLRs) 2 and 4 signaling pathways and p53 in regulating angiogenesis and apoptosis in an animal model of NMIBC, as well as, compared these mechanisms with BCG treatment. Results: Our results demonstrated the activation of the immune system by BCG (MyD88-dependent pathway) resulted in increased inflammatory cytokines. However, P-MAPA intravesical immunotherapy led to distinct activation of TLRs 2 and 4-mediated innate immune system, resulting in increased interferons signaling pathway (TRIF-dependent pathway), which was more effective in the NMIBC treatment. Interferon signaling pathway activation induced by P-MAPA led to increase of iNOS protein levels, resulting in apoptosis and histopathological recovery. Additionally, P-MAPA immunotherapy increased wild-type p53 protein levels. The increased wild-type p53 protein levels were fundamental to NO-induced apoptosis and the up-regulation of BAX. Furthermore, interferon signaling pathway induction and increased p53 protein levels by P-MAPA led to important antitumor effects, not only suppressing abnormal cell proliferation, but also by preventing continuous expansion of tumor mass through suppression of angiogenesis, which was characterized by decreased VEGF and increased endostatin protein levels. Conclusions: Thus, P-MAPA immunotherapy could be considered an important therapeutic strategy for NMIBC, as well as, opens a new perspective for treatment of patients that are refractory or resistant to BCG intravesical therapy.
Subject: Bladder Cancer
Toll-like Receptor
P53
Immunotherapy
P-mapa
Angiogenesis
Bacillus Calmette-guerin
Editor: Biomed Central Ltd
London
Rights: aberto
Identifier DOI: 10.1186/s12885-016-2474-z
Address: https://bmccancer.biomedcentral.com.ez88.periodicos.capes.gov.br/articles/10.1186/s12885-016-2474-z
Date Issue: 2016
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File SizeFormat 
000381196500003.pdf3.09 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.